Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Breast Diseases
×
ribociclib
×
Clear all
Filters
3
NCT04964934
2026-01-16
SERENA-6
AstraZeneca
Phase 3
Active not recruiting
315 enrolled
NCT02422615
2023-11-30
MONALEESA-3
Novartis
Phase 3
Completed
726 enrolled
17 charts
1 FDA